About
Tech entrepreneur turned longevity researcher. Founded Braintree/Venmo, sold for $800M, now dedicates his resources to reversing biological aging through his Blueprint protocol. Documents everything publicly - biomarkers, interventions, results. Controversial for extreme approach but provides unprecedented transparency into n=1 longevity experimentation.
Areas of Expertise
Notable Work
Blueprint protocol - comprehensive longevity regimen with documented biomarker improvements. Claims to have reversed biological age by 5+ years. Publishes all protocols, supplements, and data openly.